Oral treatment options for degenerative joint disease--presence and future

Advanced Drug Delivery Reviews
Jürgen Steinmeyer, Yrjö T Konttinen

Abstract

Alleviation of pain and inhibition of inflammation are the primary goals of pharmacotherapy of osteoarthritis (OA). These therapeutic goals can almost always be accomplished by the use of analgesics and nonsteroidal anti-inflammatory drugs (NSAID). One of the main problems of NSAIDs is their gastrointestinal toxicity, for which a prophylactic medication should be considered particularly amongst risk groups. Recent studies have shown that COX-2-selective and maybe also non-selective NSAIDs increase the cardiovascular risk so that their application is getting now drastically restricted. Pharmacological results published until now suggest that a clinically relevant minor analgesic and/or anti-inflammatory effect can be attained with the use of some of the SYmptomatic Slow Acting Drugs in OA (SYSADOAs). However, no clinical studies exist, which can positively confirm prevention, slowing down or reversal of any advanced joint cartilage destruction by any individual medication. Disease modifying therapy is still in its infancy; discovery and development of novel therapeutic targets and agents are an extremely difficult task, currently challenging many pharmaceutical companies and academic institutions.

Citations

Apr 26, 2007·Angiogenesis·Carla CostaRaquel Soares
Nov 1, 2011·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·Elizaveta KonStefano Della Villa
Sep 8, 2009·Current Medical Research and Opinion·M A MibielliA S da Fonseca
Feb 29, 2008·Journal of Pharmaceutical Sciences·Claus LarsenPia H Andersen
Aug 5, 2009·Drug Discovery Today·Johann ClouetJérôme Guicheux
Jul 21, 2006·Annals of the New York Academy of Sciences·Yrjö T KonttinenJari Salo
Nov 1, 2008·Arthritis and Rheumatism·Mari AinolaYrjö T Konttinen
Dec 20, 2011·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Katherine A BoyerThomas P Andriacchi
Jan 14, 2010·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Jürgen SteinmeyerHenning Stürz
Apr 7, 2016·Osteoarthritis and Cartilage·Marta K KosinskaJuergen Steinmeyer
Sep 20, 2012·International Journal of Pharmaceutics·Ling CheXiaohui Li
Jun 29, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Anna Buus FrostClaus Larsen
Jan 25, 2017·International Journal of Molecular Sciences·Saskia SchadowJuergen Steinmeyer
Dec 20, 2008·The Journal of International Medical Research·E C Huskisson
Apr 24, 2013·Bone & Joint Research·C W McIlwraithC E Kawcak
Dec 18, 2018·Current Medicinal Chemistry·Yichao WanZilong Tang
Nov 25, 2011·Deutsches Ärzteblatt International·Henning MadryGunnar Knutsen
Jan 21, 2021·Journal of Functional Morphology and Kinesiology·Graziana MonacoMartin J Stoddart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Per QvistMorten A Karsdal
Advanced Drug Delivery Reviews
Nicole GerwinAndrea Lucke
© 2022 Meta ULC. All rights reserved